HALO logo
halo search icon
Cue Biopharma, Inc.

US$20.43

Price Change Indicator
0.13 (0.64%)
Cue Biopharma, Inc.
CUE · NAS

Cue Biopharma, Inc.

Start Trading CUE for Free

US$20.43

Price Arrow0.13 (0.64%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleEMA 125 BreakupHALO AllHALO Consensus ValueHammer BearishHammer Bullish (Realtime)+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Cue Biopharma, Inc. Overview

CUE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CUE

icon
icon

Telephone

1.617.949.2680

icon

Address

40 Guest Street, Boston, MA 02135

Description

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

CUE Price Chart

Key Stats

Market Cap

US$82.13M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.97 - 41.42

Trade Value (12mth)

US$1,101,241.00

1 week

-11.78%

1 month

1%

YTD

100.55%

1 year

12.55%

All time high

950.70

Key Fundamentals

EPS 3 yr Growth

-81.10%

EBITDA Margin

-95.30%

Operating Cashflow

-$22m

Free Cash Flow Return

-91.90%

ROIC

-112.70%

Interest Coverage

-73.30

Quick Ratio

2.70

Other Data

Shares Outstanding (Fully Diluted)

5m

HALO Sector

Healthcare

Next Company Report Date

23-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CUE Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
15 May 26
15 May 26
15 May 26

CUE Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-33.26-21.66-8.42locklocklock
EPS (Fully Diluted)
 $locklocklocklock-33.26-21.66-8.42locklocklock
Growth
 %locklocklocklock25.434.961.1locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Cue Biopharma, Inc. (CUE:NAS)?
Halo FAQ
The current share price of Cue Biopharma, Inc. (CUE:NAS) is USD$20.43.
What is the 52-week high share price for Cue Biopharma, Inc. (CUE:NAS)?
Halo FAQ
The 52-week high share price for Cue Biopharma, Inc. (CUE:NAS) is USD$41.42.
What is the 52-week low share price for Cue Biopharma, Inc. (CUE:NAS)?
Halo FAQ
The 52-week low share price for Cue Biopharma, Inc. (CUE:NAS) is USD$4.97.
What is the dividend yield for Cue Biopharma, Inc. (CUE:NAS)?
Halo FAQ
Cue Biopharma, Inc. (CUE:NAS) does not pay a dividend.
What was Cue Biopharma, Inc. (CUE:NAS) last dividend payment?
Halo FAQ
Cue Biopharma, Inc. (CUE:NAS) does not pay a dividend.
What is the franking level for Cue Biopharma, Inc. (CUE:NAS)?
Halo FAQ
Cue Biopharma, Inc. (CUE:NAS) has a franking level of 0.00%.
In which sector is Cue Biopharma, Inc. (CUE:NAS) classified?
Halo FAQ
Cue Biopharma, Inc. (CUE:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial